Anticonvulsant effects of N6-cyclohexyladenosine microinjected into the CA1 region of the hippocampus on entorhinal cortex-kindled seizures in rats

Epileptic Disorders

Volumn 8, Issue 4, 2006, Pages 259-266

  Heidarianpour, Ali ^a,b   Sadeghian, Efat ^c   Mirnajafi Zadeh, Javad ^a   Fathollahi, Yaghoub ^a   Mohammad Zadeh, Mohammad ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b BU ALI SINA UNIVERSITY   (Iran)

^c Hamadan University of Medical Sciences   (Iran)

Author keywords

Adenosine; Entorhinal cortex; Hippocampal CA1 region; Kindling; Seizure

Indexed keywords

1,3 DIMETHYL 8 CYCLOPENTHYLXANTHINE; ADENOSINE A1 RECEPTOR ANTAGONIST; ANTICONVULSIVE AGENT; CYCLOHEXYLADENOSINE; ADENOSINE; DRUG DERIVATIVE; N(6) CYCLOHEXYLADENOSINE; N(6)-CYCLOHEXYLADENOSINE;

AFTERDISCHARGE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ELECTROSTIMULATION; ENTORHINAL CORTEX; HIPPOCAMPUS; HISTOPATHOLOGY; LATENT PERIOD; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; ANIMAL; CYTOLOGY; DISEASE MODEL; KINDLING; MICROINJECTION; PHYSIOLOGY; PYRAMIDAL NERVE CELL; SPRAGUE DAWLEY RAT;

ADENOSINE; ANIMALS; ANTICONVULSANTS; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; KINDLING, NEUROLOGIC; MALE; MICROINJECTIONS; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33845473852     PISSN: 12949361     EISSN: None     Source Type: Journal    
DOI: 10.1684/epd.2006.0037     Document Type: Article

References (39)

1. Alasvand Zarasvand M, Mirnajafi-Zadeh J, Fathollahi Y, et al. Anticonvulsant effect of bilateral injection of N6-cyclohexyladenosine into the CA1 region of the hippocampus in amygdala-kindled rats. Epilepsy Res 2001; 47: 141-9.
2. Anschel DJ, Onega EL, Kraus AC, et al. Focally injected adenosine prevents seizures in the rat. Exp Neurol 2004; 190: 544-57.
3. Barbarosie M, Avoli M. CA3-driven hippocampal-entorhinal loop controls rather than sustains in vitro limbic seizures. J Neurosci 1997; 17: 9308-14.
4. Barbarosie M, Louvel J, Kurcewicz I, et al. CA3-released entorhinal seizures disclose dentate gyrus epileptogenicity and unmask a temporoammonic pathway. J Neurophysiol 2000; 83: 1115-24.
5. Behr J, Gloveli T, Gutie'rrez R, et al. Spread of low Mg2+ induced epileptiform activity from the rat entorhinal cortex to the hippocampus after kindling studied in vitro. Neurosci Lett 1996; 216: 41-4.
6. Behr J, Lyson KJ, Mody I. Enhanced propagation of epileptiform activity through the kindled dentate gyrus. J Neurophysiol 1998; 79: 1726-32.
7. Bradford HF. Glutamate, GABA and Epilepsy. Prog Neurobiol 1995; 47: 477-511.
8. Boison D. Adenosine and epilepsy: from therapeutic rationale to new therapeutic strategies. Neuroscientist 2005; 11: 25-36.
9. Chen Y, Graham DI, Stone TW. Release of endogenous adenosine and its metabolites by the action of NMDA receptors in the rat hippocampus in vivo. Br J Pharmacol 1992; 106: 632-8.
10. Cunha RA, Johansson B, van der Ploeg I, et al. Evidence for functionally important adenosine A2A receptors in the rat hippocampus. Brain Res 1994; 649: 208-16.
11. Dragunow M. Purinergic mechanisms in epilepsy. Prog Neurobiol 1988; 31: 5-108.
12. Dugladze T, Heinemann U, Gloveli T. Endorhinal cortex projection cells to the hippocampal formation in vitro. Brain Res 2001; 905: 224-31.
13. Dunwiddie TV, Masino SA. The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci 2001; 24: 31-55.
14. During MJ, Spencer DD. Adenosine: A potential mediator of seizure arrest and postictal refractoriness. Ann Neurol 1992; 32: 618-24.
15. Fredholm BB, Jzerman AP, Jacobson KA, et al. International Union of Pharmacology: XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 2001; 53: 527-52.
16. Fredholm BB, Chen JF, Cunha RA, et al. Adenosine and brain function. Int Rev Neurobiol 2005; 63: 191-270.
17. Gouder N, Fritschy JM, Boison D. Seizure suppression by adenosine A1 receptor activation in a mouse model of pharmacoresistant epilepsy. Epilepsia 2003; 44: 877-85.
18. Heinemann U, Beck H, Dreier JP, et al. The dentate gyrus as a regulated gate for the propagation of epileptiform activity. In: Ribak CE, Gall CM, Mody I, eds. The Dentate gyrus and its role in seizures. Amsterdam: Elsevier science publishers BV, 1992: 273-80.
19. Herberg LJ, Rose IC, Mintz M. Effect of an adenosine A1 agonist injected into substantia nigra on kindling of epileptic seizures and convulsion duration. Pharmacol Biochem 1993; 44: 113-7.
20. Huber A, Guttinger M, Mohler H, Boison D. Seizure suppression by adenosine A2A receptor activation in a rat model of audiogenic brainstem epilepsy. Neurosci Lett 2002; 329: 289-92.
21. Jeong HJ, Jang IS, Nabekura J, et al. Adenosine A1 receptor-mediated presynaptic inhibition of GABAergic transmission in immature rat hippocampal CA1 neurons. J Neurophysiol 2003; 89(3): 1214-22.
22. Lee KS, Schubert P, Heinemann U. The anticonvulsive action of adenosine: a postsynaptic, dendritic action by a possible endogenous anticonvulsant. Brain Res 1984; 321: 160-4.
23. Mirnajafi-Zadeh J, Pourgholami MH, Palizvan MR, Rostampour M, Fallahi M. Anti convulsant action of 2-chloroadenosine injected Focally into the Perirhinal cortex in amygdaloid kindled rats. Epilepsy Res 1999; 37(1): 37-43.
24. Mirnajafi-Zadeh J, Fathollahi Y, Pourgholami MH. Intraperitoneal and intraamygdala N6-cyclohexyladenosine suppress hippocampal kindled seizures in rats. Brain Res 2000; 858: 48-54.
25. Mohammad-Zadeh M, Amini A, Mirnajafi-Zadeh J, Fathollahi Y. The role of adenosine A1 receptors in the interaction between amygdala and entorhinal cortex of kindled rats. Epilepsy Res 2005; 65: 1-9.
26. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. New York: Academic Press, 1986.
27. Pourgholami MH, Mirnajafi-Zadeh J, Behzadi J. Effect of intraperitoneal and intrahippocampal (CA1) 2- chloroadenosine in amygdaloid kindled rats. Brain Res 1997; 751: 259-64.
28. Pourgholami MH, Rostampour M, Mirnajafi-Zadeh J, et al. Intra-amygdala infusion of 2-chloroadenosine suppresses amygdala-kindled seizures. Brain Res 1997; 775: 37-42.
29. Racine RJ. Modulation of seizure activity by electrical stimulation 2. Motor seizure. Electroencephalogr Clin Neurophysiol 1972; 132: 281-94.
30. Ribeiro JA, Sebastiao AM, de Mendonca A. Participation of adenosine receptors in neuroprotection. Drug News Perspect 2003; 16: 80-6.
31. Rosen LB, Berman RF. Differential effects of adenosine analogs on amygdala, hippocampus and caudate nucleus kindled seizures. Epilepsia 1987; 28: 658-66.
32. Sagratella S, Frank C, Benedetti L, et al. Modulatory action of purinergic drugs on high potassium induced epileptiform bursting in rat hippocampal slices. Pharmacol Res Com 1987; 19: 819-26.
33. Sato M, Racine RJ, McIntyre DC. Kindling: basic mechanisms and clinical validity. Electroencephalogr Clin Neurophysiol 1990; 76: 459-72.
34. Tanaka T, Kondom S, Hori T, et al. Various hippocampal lesions induced by multi-fractional ibotenic acid injection and amygdala kindling in rats. Brain Res 1991; 559: 154-8.
35. Thompson SM, Hass HL, Gahvailer BH. Comparison of the action of adenosine at pre and post synaptic receptors in the hippocampus in vitro. J Physiol 1992; 451: 347-63.
36. Wozny C, Gabriel S, Jandova K, et al. Endorhinal cortex entrains epileptiform activity in CA1 in pilocarpine-treated rats. Neurobiol Dis 2005; 19: 451-60.
37. Wu LG, Saggau P. Adenosine inhibits evoked synaptic transmission primarily by reducing pre synaptic calcium influx in area CA1 of the hippocampus. Neuron 1994; 12: 1139-48.
38. Yoon KW, Rothman SM. The modulation of rat hippocampal synaptic conductances by baclofen and gamma-aminobutyric acid. J Physiol 1991; 442: 377-90.
39. Zeraati M, Mirnajafi-Zadeh J, Fathollahi Y, et al. Adenosine A1 and A2A receptors of hippocampal CA1 region have opposite effects on piriform cortex kindled seizures in rats. Seizure 2006; 15: 41-8.